| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/10/1997 | CA2229434A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | CA2207084A1 Controlled release matrix for pharmaceuticals |
| 04/09/1997 | EP0767174A1 Novel aminoalkanephosphinic acids and their salts |
| 04/09/1997 | EP0766696A1 Thiazolidine derivatives, their preparation and drugs containing same |
| 04/09/1997 | EP0766695A1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
| 04/09/1997 | EP0766684A1 Endothelin receptor antagonists |
| 04/09/1997 | EP0766680A1 Substituted dihydrobenzofuran derivatives as 5-ht 4 agonists |
| 04/09/1997 | EP0766565A1 Medical use of bromelain |
| 04/09/1997 | EP0766562A1 Therapeutical compositions comprising 3-phenyl-3-hydroxypiperidines |
| 04/09/1997 | EP0766561A1 Utilisation of derivatives of 1,2,5,6-tetrahydropyridine for the preparation of sedative medicaments |
| 04/09/1997 | EP0766559A1 Cannabinoid receptor antagonists |
| 04/09/1997 | EP0766558A1 Transdermal therapeutic system with active substances constituting sources of carbon monoxide |
| 04/09/1997 | EP0766538A1 Subcutaneous implant |
| 04/09/1997 | EP0675890B1 Condensed benzo(d)isoxazole derivatives and their use as psychoactive agents |
| 04/09/1997 | EP0666912B1 Modified ciliary neurotrophic factors |
| 04/09/1997 | EP0599890B1 Geneserine derivatives as cholinesterase inhibitors |
| 04/09/1997 | CN1147260A Neurokinine (tachykinine) antagonists |
| 04/09/1997 | CN1147254A Prodrugs of morpholine tachykinin receptor antagonists |
| 04/09/1997 | CN1147201A Halomethyl amides as IL-1 'beta' protease inhibitors |
| 04/09/1997 | CN1146992A Process for preparation of intermediate (R)-3-amino-5-methoxychroman |
| 04/09/1997 | CN1146987A 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients |
| 04/08/1997 | US5618947 Separating the racemic mixture by chromatography |
| 04/08/1997 | US5618938 Process for preparing stereo isomers of neurokinin receptor antagonists |
| 04/08/1997 | US5618850 Hydroxy-acid cosmetics |
| 04/08/1997 | US5618845 Acetamide derivative having defined particle size |
| 04/08/1997 | US5618835 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 04/08/1997 | US5618833 1-benzyl-1,3-dihydroindol-2-one derivatives, their preparation and the pharmaceutical compositions in which they are present |
| 04/08/1997 | US5618819 1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-(3H)-one compounds |
| 04/08/1997 | US5618817 Use of diphenylbutyl-piperazinecarboxamides in the treatment of substance disorders |
| 04/08/1997 | US5618816 Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines |
| 04/08/1997 | US5618812 Benzodiazepine derivatives |
| 04/08/1997 | US5618811 Gastrointestinal and central nervous system disorders |
| 04/08/1997 | US5618808 Benzothiazepine and benzoxazepine derivatives as cholecystokinin receptor antagonists |
| 04/08/1997 | US5618563 Encapsulating an anesthetic drug into biocompatiable microparticles |
| 04/08/1997 | US5618555 Percutaneous absorption preparation |
| 04/08/1997 | US5618516 Composition also containing water, thickener, emulsifier, propellant; applied as foam for maximum penetration |
| 04/08/1997 | CA2091204C Antiischemic-piperazinyl and piperidinyl-cyclohexanes |
| 04/03/1997 | WO1997012055A1 Product and process to regulate actin polymerization |
| 04/03/1997 | WO1997012037A1 A novel haemopoietin receptor and genetic sequences encoding same |
| 04/03/1997 | WO1997011965A1 Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 04/03/1997 | WO1997011964A1 Truncated glial cell line-derived neurotrophic factor |
| 04/03/1997 | WO1997011956A1 IDENTIFICATION OF sel-12 AND USES THEREOF |
| 04/03/1997 | WO1997011700A1 Method for treating a tic disorder |
| 04/03/1997 | WO1997011696A1 Transdermal administration of ropinirole and analogs thereof |
| 04/03/1997 | WO1997011695A1 Substituted indolylpropyl-piperazine derivatives as 5-ht1dalpha agonists |
| 04/03/1997 | WO1997009317A3 Optically active phenyl pyrimidine derivative as analgesic agent |
| 04/03/1997 | WO1997003192A3 Chromosome 1 gene and gene products related to alzheimer's disease |
| 04/03/1997 | CA2233334A1 Transdermal administration of ropinirole and analogs thereof |
| 04/03/1997 | CA2233297A1 Identification of sel-12 and uses thereof |
| 04/03/1997 | CA2232559A1 Method for treating a tic disorder |
| 04/03/1997 | CA2232260A1 Substituted indolylpropyl-piperazine derivatives as 5-ht1dalpha agonists |
| 04/03/1997 | CA2230121A1 Product and process to regulate actin polymerization |
| 04/02/1997 | EP0765877A1 5,6,7,8-Tetrahyronaphto(2,3-b)furan- and indano(5,6-b)furan-amino-compounds, processes for their preparation and pharmaceutical compositions containing them |
| 04/02/1997 | EP0765668A1 Extract of Iridaceas and composition containing it |
| 04/02/1997 | EP0765327A1 Pyrazolo and pyrrolopyridines |
| 04/02/1997 | EP0765326A1 Benzoylecgonine, ecgonine and ecgonidine derivatives |
| 04/02/1997 | EP0765325A1 Novel 1,1-bis(heteroazolyl)alkane derivatives and their use as neuroprotective agents |
| 04/02/1997 | EP0765323A1 4-(6-fluoro-1,2-benzisoxazolyl)-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis, schizophrenia and anxiety |
| 04/02/1997 | EP0765322A1 Indole derivatives as prodrugs of 5-ht 1?-like receptor agonists |
| 04/02/1997 | EP0765320A1 Benzimidazolone derivatives with central dopaminergic activity |
| 04/02/1997 | EP0765314A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 04/02/1997 | EP0765311A1 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl)piperidines, tetrahydropyridines or piperazines |
| 04/02/1997 | EP0765169A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
| 04/02/1997 | EP0765160A1 Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions |
| 04/02/1997 | EP0674511B1 Antipyretic and analgesic compositions containing optically pure r-ketorolac |
| 04/02/1997 | EP0659172B1 Analogues of vpa used as anti-epileptica |
| 04/02/1997 | EP0623127B1 Novel neurotransmitter releasers useful for cognition enhancement |
| 04/02/1997 | EP0587625B1 N-arylalkylderivatives of 2-aminomethyl-2,3-dihydro-1,4-benzodioxine and the process of preparation thereof |
| 04/02/1997 | EP0573465B1 Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same |
| 04/01/1997 | US5616724 Fused pyrrolo[2,3-c]carbazole-6-ones |
| 04/01/1997 | US5616707 N-methyl-4-pyridyl-3-but(ene or yne)-1-amine |
| 04/01/1997 | US5616705 Useful in the control of diseases |
| 04/01/1997 | US5616618 Administering to treat chronic pain |
| 04/01/1997 | US5616614 Useful in treatment of disorders linked to abnormal melatonin activity |
| 04/01/1997 | US5616601 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation |
| 04/01/1997 | US5616596 Substituted arylalkynyl-and heteroarylalkynl-N-hydroxyurea inhibitors of leukotriene biosynthesis |
| 04/01/1997 | US5616592 Useful for disorders of cardiovascular, gastrointestinal and psychological disorders |
| 04/01/1997 | US5616587 Aqueous risperidone formulations |
| 04/01/1997 | US5616586 Tricyclic quinoxalinediones |
| 04/01/1997 | US5616585 Pyridopyrazine derivatives for treating alcohol and nicotine abuse and addiction |
| 04/01/1997 | US5616575 Bioactive tricyclic ibogaine analogs |
| 03/27/1997 | WO1997011073A1 Novel substituted azacyclic or azabicyclic compounds |
| 03/27/1997 | WO1997011072A1 Novel substituted azacyclic or azabicyclic compounds |
| 03/27/1997 | WO1997011071A1 Novel heterocyclic compounds |
| 03/27/1997 | WO1997011056A1 Indole derivatives as melatoninergic analogues |
| 03/27/1997 | WO1997010835A1 Anti-intoxication composition |
| 03/27/1997 | WO1997010827A1 Use of antimineralocorticoid compounds against drug withdrawal syndrome |
| 03/27/1997 | WO1997010823A1 5-ht3 receptor antagonists for dyskinesia |
| 03/27/1997 | WO1997010712A1 Inhibition of tumor necrosis factor alpha |
| 03/27/1997 | WO1997004780A3 Pain-alleviating drug composition and method for alleviating pain |
| 03/27/1997 | WO1996040043A3 Neuroactive steroids of the androstane and pregnane series |
| 03/27/1997 | CA2231887A1 5-ht3 receptor antagonists for dyskinesia |
| 03/27/1997 | CA2231835A1 Novel heterocyclic compounds |
| 03/27/1997 | CA2229796A1 Anti-intoxication composition |
| 03/26/1997 | EP0764273A1 Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis |
| 03/26/1997 | EP0764166A1 Corticotropin releasing factor antagonists |
| 03/26/1997 | EP0764163A1 Tachykinin (nk 1) receptor antagonists |
| 03/26/1997 | EP0764162A1 Cyclobut-3-ene-1,2-dione derivatives as smooth muscle relaxants |
| 03/26/1997 | EP0764159A1 C -4 amide substituted compounds and their use as therapeutic agents |
| 03/26/1997 | EP0764158A1 Benzopyrans and their use as therapeutic agents |